Atlas Trials

Interplay Between Immune and Metabolic Programs in Myelodysplastic Syndromes

Clinical trial NCT04803721 · COMPLETED

Trial details

NCT number
NCT04803721
Sponsor
University Hospital, Toulouse
Status
COMPLETED
Study type
OBSERVATIONAL
Myelodysplastic Syndromes
Start date
2021-02-23
Primary completion
2024-01-01
Enrollment
137

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.